Deal snapshot: Renovaro Biosciences to Combine with GEDi Cube to Accelerate Personalised Medicine for Longevity.

MANews-(C)2009-2023

US-based preclinical biotechnology firm Renovaro Biosciences Inc. (NASDAQ: RENB) has agreed to combine with Netherlands-based AI medical technology company GEDi Cube Intl Ltd., the company said.

The Transaction is structured as a stock-for-stock acquisition whereby all of GEDi...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT